Archived Monthly Oncology Tumor Boards: Management of Pheochromocytoma and Paraganglioma
It is important to keep clinicians up to date with NCCN Guidelines for Neuroendocrine and Adrenal Tumors recommendations and with emerging data from clinical studies as this may help optimize treatment selection and ultimately improve clinical outcomes.
Category
  • Neuroendocrine Tumors
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation
May 2023 BCOP Test - The Role of PD-L1 Therapy in the Early Treatment of Triple Negative Breast Cancer
The test is available for an additional fee of $50. Each activity is this series is worth 1 hour of BCOP credit. Save $10 per test by purchasing the 6-test bundle!
Category
Format
Credits
June 2023 BCOP Test - Updates on Targeted Therapy for the Treatment of Thyroid Carcinoma
The test is available for an additional fee of $50. Each activity is this series is worth 1 hour of BCOP credit. Save $10 per test by purchasing the 6-test bundle!
Category
Format
Credits
September 2023 BCOP Test - Ampullary Adenocarcinoma: Overview of Subtypes and Treatments
The test is available for an additional fee of $50. Each activity is this series is worth 1 hour of BCOP credit. Save $10 per test by purchasing the 6-test bundle!
Category
Format
Credits
December 2023 BCOP Test - Advances in Targeted Therapy for Biliary Tract Cancers
The test is available for an additional fee of $50. Each activity is this series is worth 1 hour of BCOP credit. Save $10 per test by purchasing the 6-test bundle!
Category
Format
Credits
December 2023 BCOP Test - Updates in the Treatment of Adult Acute Lymphoblastic Leukemia
The test is available for an additional fee of $50. Each activity is this series is worth 1 hour of BCOP credit. Save $10 per test by purchasing the 6-test bundle!
Category
Format
Credits
Recorded Presentations from the NCCN 2023 Annual Congress: Hematologic Malignancies™
This program features updates to the NCCN Guidelines; new, emerging and novel therapeutic agents; advances in cancer care; and the practical management of patients with hematologic malignancies, including acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia/small lymph
Category
Format
Credits
NCCN 2024 Pharmacy Updates: A Webinar Series
This program will provide up-to-date knowledge and skills related to the management of cancer and highlight the importance of interprofessional care and collaboration to ensure the best possible outcomes for patients with cancer.
Category
Format
Credits
Monthly Oncology Tumor Boards: B-Cell Lymphomas: Histologic Transformation of Indolent Lymphomas
Learn about the challenges associated with the management of transformed indolent lymphomas and the recent advances in management to help you to incorporate novel therapies into routine clinical practice in the appropriate patient population to improve clinical outcomes.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Live Webinar
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation
Event date May 29, 2024
NCCN Pharmacy Updates: Updates in Ovarian Cancer - Putting Together the PARP Puzzle and Understanding a New Therapeutic Target
The flurry of changes to the PARPi indications can cause considerable confusion in clinical practice. It may be difficult for health care professionals to keep track of the emerging data and understand how to apply it to patient care. It is important that health care professionals, including pharmacists, are able to educate their patients on the risks vs. benefits of these agents to help empower them to make informed decisions regarding their treatment.
Category
  • Ovarian Cancer
Format
  • Live Webinar
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Event date May 30, 2024

Pages